Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve 1. To Consider and Approve the unaudited standalone financial results for the quarter and half year ended 30th September, 2025 along with Limited Review Report of the auditors;2. Any other matter with the permission of chair.